- Home
- QSI vs RPID Comparison
QSI vs RPID Comparison
Compare QSI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | RPID |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | 145 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 204.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | QSI | RPID |
|---|---|---|
| Price | $1.04 | $2.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.00 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 6.9M | 148.9K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | $618.07 | $18.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $0.69 | $1.86 |
| 52 Week High | $3.10 | $4.94 |
Technical Indicators
Market Signals| Indicator | QSI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 38.27 |
| Support Level | $0.88 | $1.86 |
| Resistance Level | $1.08 | $2.46 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 45.26 | 41.94 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.